Atlas FDA

XIENCE V Everolimus Eluting Coronary Stent System / XIENCE nano Everolimus Eluting Coronary Stent System

FDA premarket approval P070015/S138 · decided 2018-01-25

Approval details

PMA number
P070015
Supplement
S138
Supplement type
135 Review Track For 30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
XIENCE V Everolimus Eluting Coronary Stent System / XIENCE nano Everolimus Eluting Coronary Stent System
Generic name
Coronary drug-eluting stent
Applicant
Abbott Vascular, Inc.
Date received
2017-09-28
Decision date
2018-01-25
Days to decision
119 days
Decision code
APPR
Product code
NIQ
Advisory committee
Cardiovascular
Expedited review
No
Location
Temecula, CA
Statement
Approval to change the ethylene oxide (EO) sterilization release process for the affected products from using the traditional method of biological indicator testing to a parametric release process.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Hi-Torque JET Guide Wire Family (K142415)Abbott Vascular, Inc.2014-12-19
PROGRESS GUIDE WIRE FAMILY, PILOT GUIDE WIRE FAMILY (K123067)Abbott Vascular, Inc.2013-01-29
HI-TORQUE COMMAND GUIDE WIRE FAMILY (K122573)Abbott Vascular, Inc.2012-11-20
ARMADA 14 PTA CATHETER (K102705)Abbott Vascular, Inc.2010-12-07
HI-TORQUE WINN GUIDE WIRE FAMILY (K101648)Abbott Vascular, Inc.2010-07-08
HI-TORQUE BALANCE MIDDLEWEIGHT UNIVERSAL (K101011)Abbott Vascular, Inc.2010-05-24
HI-TORQUE PROGRESS GUIDE WIRE FAMILY (K091825)Abbott Vascular, Inc.2009-09-25
FOXCROSS PTA CATHETER (K081417)Abbott Vascular, Inc.2008-06-04